(Q50473903)

English

A two-stage, single-arm, phase II study of EGCG-enriched green tea drink as a maintenance therapy in women with advanced stage ovarian cancer.

scientific article published on 27 August 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23988418

A two-stage, single-arm, phase II study of EGCG-enriched green tea drink as a maintenance therapy in women with advanced stage ovarian cancer. (English)

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23988418

1 reference

based on heuristic

inferred from title

Laurent Bazinet

5

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23988418

Dimcho Bachvarov

0 references

author name string

Dominique Trudel

1

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23988418

David P Labbé

2

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23988418

Monica Araya-Farias

3

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23988418

Alain Doyen

4

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23988418

Thierry Duchesne

6

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23988418

Marie Plante

7

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23988418

Jean Grégoire

8

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23988418

Marie-Claude Renaud

9

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23988418

Dimcho Bachvarov

10

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23988418

Bernard Têtu

11

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23988418

Isabelle Bairati

12

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23988418

language of work or name

0 references

publication date

27 August 2013

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23988418

Gynecologic Oncology

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23988418

131

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23988418

2

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23988418

357-361

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23988418

Treatment goals in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.019

7 January 2021

Achievements and unmet needs in the management of advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.019

7 January 2021

Continued chemotherapy after complete response to primary therapy among women with advanced ovarian cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.019

7 January 2021

Molecular targets of phytochemicals for cancer prevention

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.019

7 January 2021

Green and black tea in relation to gynecologic cancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.019

7 January 2021

Green tea for ovarian cancer prevention and treatment: a systematic review of the in vitro, in vivo and epidemiological studies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.019

7 January 2021

Epicatechins Purified from Green Tea (Camellia sinensis) Differentially Suppress Growth of Gender-Dependent Human Cancer Cell Lines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.019

7 January 2021

Epigallocatechin 3-gallate and green tea catechins: United they work, divided they fail

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.019

7 January 2021

Production of green tea EGC- and EGCG-enriched fractions by a two-step extraction procedure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.019

7 January 2021

Green tea consumption enhances survival of epithelial ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.019

7 January 2021

Optimal two-stage designs for phase II clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.019

7 January 2021

CA-125 criteria for response evaluation in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.019

7 January 2021

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.019

7 January 2021

Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.019

7 January 2021

Electromigration feasibility of green tea catechins

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.019

7 January 2021

Catechin stability of EGC- and EGCG-enriched tea drinks produced by a two-step extraction procedure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.019

7 January 2021

Identifiers

10.1016/J.YGYNO.2013.08.019

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23988418

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23988418

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50473903&oldid=1370850318"